Is anti-dandruff shampoo considered an OTC drug in the U.S., and how does that change the project?

Yes, anti-dandruff shampoo is OTC in the US, requiring FDA registration and specific active ingredients like zinc pyrithione or ketoconazole.

US buyer view Launch planning Updated: January 28, 2026
Chat on WhatsApp
Best for
US brand owners, Amazon/FBA sellers, distributors, and private label buyers
Core intent
Who submits, what data is needed, and how to plan timelines before production

Quick Answer (for busy buyers)

Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.

  • Anti-dandruff shampoo is classified as an OTC drug in the US, which means it requires FDA registration and must use specific active ingredients at approved concentrations.
  • This changes the project by adding regulatory documentation requirements and testing protocols.
  • MOQ increases to 5,000 units minimum due to additional documentation and testing.
  • Sampling timeline extends to 8-12 weeks to accommodate stability and efficacy testing.
  • Packaging must include proper drug facts panels and warning statements.
  • Lead time increases by 4-6 weeks for regulatory review and documentation preparation.
  • We can support with FDA registration assistance and required testing documentation.
Buyer outcome
A launch-ready compliance plan: inputs collected, roles assigned, and update cadence defined.
Most common blocker
Missing facility information + inconsistent ingredient/label snapshots across SKUs.
⚠️
This page is a practical buyer guide. For definitive requirements and updates, use FDA resources and qualified regulatory counsel.
  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).